Ductal Carcinoma In Situ in BRCA Mutation Carriers
- 9 February 2007
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (6) , 642-647
Abstract
Purpose: The current literature suggests that ductal carcinoma in situ (DCIS) of the breast is infrequently diagnosed in patients with BRCA germline mutations. We studied women at high risk of hereditary breast cancer syndromes who underwent testing for BRCA1 and BRCA2 to estimate DCIS prevalence and incidence in known BRCA-positive women compared with high-risk women who were mutation negative. Methods: We analyzed breast event outcomes in a retrospective cohort of 129 BRCA-positive and 269 BRCA-negative women undergoing genetic testing for a BRCA mutation between September 1996 and December 2003 at University of California, San Francisco. We estimated the frequency of DCIS and invasive cancer and time to breast events from birth using a Cox proportional hazard model for competing risks. Histologic grade of DCIS was also compared between groups. Results: Among BRCA carriers, 48 (37%) had DCIS (with or without invasive cancer) compared with 92 noncarriers (34%). Univariate analysis showed that both DCIS and invasive cancer had an earlier onset in mutation carriers than in noncarriers, although on a per-woman basis, this difference was not statistically significant. High-grade DCIS was more common in BRCA1 mutation carriers than in patients without a mutation (P = .02). Conclusion: DCIS is equally as prevalent in patients who carry deleterious BRCA mutations as in high familial-risk women who are noncarriers, but occurs at an earlier age. Our results argue for the consideration of DCIS as a criterion for BRCA risk assessments with appropriate weighting in prediction models such as BRCAPRO.Keywords
This publication has 25 references indexed in Scilit:
- Prevention and Management of Hereditary Breast CancerJournal of Clinical Oncology, 2005
- BRCA1 and BRCA2: 1994 and beyondNature Reviews Cancer, 2004
- Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ Clinical Cancer Research, 2004
- Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 2004
- Characteristics Associated With Recurrence Among Women With Ductal Carcinoma In Situ Treated by LumpectomyJNCI: Journal of the National Cancer Institute, 2003
- Age at Diagnosis and Outcome for Women With Ductal Carcinoma-In-Situ of the Breast: A Critical Review of the LiteratureJournal of Clinical Oncology, 2002
- Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 MutationsJNCI: Journal of the National Cancer Institute, 1998
- Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic LociJNCI: Journal of the National Cancer Institute, 1998
- Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic casesThe Lancet, 1997
- In-situ breast cancer and BRCA 1The Lancet, 1996